129 related articles for article (PubMed ID: 37487908)
21. Comprehensive geriatric assessment as a useful tool in predicting adverse events in elderly patients with diffuse large B-cell lymphoma.
Tanaka T; Sakai R; Choi I; Tsukada J; Sasaki H; Naito Y; Kiyomi F; Takamatsu Y; Tamura K
Sci Rep; 2022 Feb; 12(1):3124. PubMed ID: 35210509
[TBL] [Abstract][Full Text] [Related]
22. Considerations for the Treatment of Diffuse Large B Cell Lymphoma in the Elderly.
Khan Y; Brem EA
Curr Hematol Malig Rep; 2019 Aug; 14(4):228-238. PubMed ID: 31228094
[TBL] [Abstract][Full Text] [Related]
23. Tailored therapy in an unselected population of 91 elderly patients with DLBCL prospectively evaluated using a simplified CGA.
Olivieri A; Gini G; Bocci C; Montanari M; Trappolini S; Olivieri J; Brunori M; Catarini M; Guiducci B; Isidori A; Alesiani F; Giuliodori L; Marcellini M; Visani G; Poloni A; Leoni P
Oncologist; 2012; 17(5):663-72. PubMed ID: 22531362
[TBL] [Abstract][Full Text] [Related]
24. [Comprehensive geriatric assessment can predict the clinical outcomes of elderly patients with diffuse large B cell lymphoma in China].
Zhang CL; Feng R; Li JT; Tian Y; Wang T; Liu H
Zhonghua Xue Ye Xue Za Zhi; 2018 Apr; 39(4):271-276. PubMed ID: 29779319
[No Abstract] [Full Text] [Related]
25. Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial.
Peyrade F; Jardin F; Thieblemont C; Thyss A; Emile JF; Castaigne S; Coiffier B; Haioun C; Bologna S; Fitoussi O; Lepeu G; Fruchart C; Bordessoule D; Blanc M; Delarue R; Janvier M; Salles B; André M; Fournier M; Gaulard P; Tilly H;
Lancet Oncol; 2011 May; 12(5):460-8. PubMed ID: 21482186
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma: a prospective multicenter evaluation in 173 patients by the Lymphoma Italian Foundation (FIL).
Tucci A; Martelli M; Rigacci L; Riccomagno P; Cabras MG; Salvi F; Stelitano C; Fabbri A; Storti S; Fogazzi S; Mancuso S; Brugiatelli M; Fama A; Paesano P; Puccini B; Bottelli C; Dalceggio D; Bertagna F; Rossi G; Spina M;
Leuk Lymphoma; 2015 Apr; 56(4):921-6. PubMed ID: 25110825
[TBL] [Abstract][Full Text] [Related]
27. Validation and Refinement of the Age, Comorbidities, and Albumin Index in Elderly Patients with Diffuse Large B-Cell Lymphoma: An Effective Tool for Comprehensive Geriatric Assessment.
Liu H; Zhang CL; Feng R; Li JT; Tian Y; Wang T
Oncologist; 2018 Jun; 23(6):722-729. PubMed ID: 29317552
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the frailty characteristics and clinical outcomes according to the new frailty-based outcome prediction model (Myeloma Risk Profile-MRP) in a UK real-world cohort of elderly newly diagnosed Myeloma patients.
Djebbari F; Rampotas A; Panitsas F; Lim WY; Lees C; Tsagkaraki I; Gomes AR; Prideaux S; Chen L; Prodger C; Khera A; Gray N; Ellis L; Sangha G; Eyre TA; Moore S; Kothari J; Ramasamy K
PLoS One; 2022; 17(1):e0262388. PubMed ID: 35015781
[TBL] [Abstract][Full Text] [Related]
29. A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study.
Mahmoud AM; Biello F; Maggiora PM; Bruna R; Burrafato G; Cappelli M; Varughese F; Martini V; Platini F; Deambrogi C; Patriarca A; Nicolosi M; Vachanaram AR; Pisani C; Ferrara E; Catania E; Azzolina D; Barone-Adesi F; Krengli M; Gaidano G; Gennari A
BMC Geriatr; 2021 May; 21(1):320. PubMed ID: 34011271
[TBL] [Abstract][Full Text] [Related]
30. [Frail-VIG index: Convergent and discriminatory validity with respect to Short Physical Performance Battery in general population].
Camacho-Torregrosa S; Albert-Ros X; Aznar-Cardona J; Mollar-Talamantes M; Bordonaba-Mateos MA; Galán-Bernardino JV
Rev Esp Geriatr Gerontol; 2023; 58(2):75-83. PubMed ID: 36842943
[TBL] [Abstract][Full Text] [Related]
31. Frailty in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Receiving Curative-Intent Therapy: A Population-Based Study.
Vijenthira A; Mozessohn L; Nagamuthu C; Liu N; Blunt D; Alibhai S; Prica A; Cheung MC
J Natl Compr Canc Netw; 2022 Jun; 20(6):635-642.e9. PubMed ID: 35714676
[TBL] [Abstract][Full Text] [Related]
32. Frailty assessment to individualize treatment in older patients with lymphoma.
Hormigo-Sanchez AI; Lopez-Garcia A; Mahillo-Fernandez I; Askari E; Morillo D; Perez-Saez MA; Riesco M; Urrutia C; Martinez-Peromingo FJ; Cordoba R; Gonzalez-Montalvo JI
Eur Geriatr Med; 2023 Dec; 14(6):1393-1402. PubMed ID: 37823983
[TBL] [Abstract][Full Text] [Related]
33. Diffuse large B-cell lymphoma in the elderly: impact of prognosis, comorbidities, geriatric assessment, and supportive care on clinical practice. An International Society of Geriatric Oncology (SIOG) expert position paper.
Morrison VA; Hamlin P; Soubeyran P; Stauder R; Wadhwa P; Aapro M; Lichtman S
J Geriatr Oncol; 2015 Mar; 6(2):141-52. PubMed ID: 25491101
[TBL] [Abstract][Full Text] [Related]
34. Clinical impact of comprehensive geriatric assessment in patients aged 80 years and older with diffuse large B-cell lymphoma receiving rituximab-mini-CHOP: a single-institute retrospective study.
Yamasaki S; Matsushima T; Minami M; Kadowaki M; Takase K; Iwasaki H
Eur Geriatr Med; 2022 Feb; 13(1):195-201. PubMed ID: 34254266
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of Frailty in Older Community-Dwelling Tanzanians According to Comprehensive Geriatric Assessment.
Lewis EG; Wood G; Howorth K; Shah B; Mulligan L; Kissima J; Dotchin C; Gray W; Urasa S; Walker R
J Am Geriatr Soc; 2018 Aug; 66(8):1484-1490. PubMed ID: 29897098
[TBL] [Abstract][Full Text] [Related]
36. Rituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the
Storti S; Spina M; Pesce EA; Salvi F; Merli M; Ruffini A; Cabras G; Chiappella A; Angelucci E; Fabbri A; Liberati AM; Tani M; Musuraca G; Molinari A; Petrilli MP; Palladino C; Ciancia R; Ferrario A; Gasbarrino C; Monaco F; Fraticelli V; De Vellis A; Merli F; Luminari S
Haematologica; 2018 Aug; 103(8):1345-1350. PubMed ID: 29748444
[TBL] [Abstract][Full Text] [Related]
37. Frailty and Mortality Risk in COPD: A Cohort Study Comparing the Fried Frailty Phenotype and Short Physical Performance Battery.
Brighton LJ; Nolan CM; Barker RE; Patel S; Walsh JA; Polgar O; Kon SSC; Gao W; Evans CJ; Maddocks M; Man WDC
Int J Chron Obstruct Pulmon Dis; 2023; 18():57-67. PubMed ID: 36711228
[TBL] [Abstract][Full Text] [Related]
38. Utility of the Geriatric 8 for the Prediction of Therapy-Related Toxicity in Older Adults with Diffuse Large B-Cell Lymphoma.
Oiwa K; Fujita K; Lee S; Morishita T; Tsukasaki H; Negoro E; Ueda T; Yamauchi T
Oncologist; 2021 Mar; 26(3):215-223. PubMed ID: 33320984
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and determinants of physical frailty among people living in residential aged care facilities: a large-scale retrospective audit.
Milte R; Petersen J; Boylan J; Henwood T; Hunter S; Lange B; Lawless M; Torode S; Lewis LK
BMC Geriatr; 2022 May; 22(1):424. PubMed ID: 35568811
[TBL] [Abstract][Full Text] [Related]
40. Diffuse Large B-cell Lymphoma in the elderly: standard treatment and new perspectives.
Chiappella A; Castellino A; Nicolosi M; Santambrogio E; Vitolo U
Expert Rev Hematol; 2017 Apr; 10(4):289-297. PubMed ID: 28290728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
